Cited by 62Hyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Management and ResearchDiabetes Treatment and Management

Diabetes technology in the inpatient setting for management of hyperglycemia

Open access
Davis, Georgia M., Galindo, Rodolfo J., Migdal, Alexandra L., Umpierrez, Guillermo E.·2020·Endocrinology and Metabolism Clinics of North America

Abstract

In past decades, a rapid evolution of diabetes technology led to increased popularity and use of continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII) in the ambulatory setting for diabetes management, and recently, the artificial pancreas became available. Efforts to translate this technology to the hospital setting have shown accuracy and reliability of CGM, safety of CSII in appropriate populations, improvement of inpatient glycemic control with computerized glycemic management systems, and feasibility of inpatient CGM-CSII closed-loop systems. Several ongoing studies are focusing on continued translation of this technology to improve glycemic control and outcomes in hospitalized patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ecl.2019.11.002

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Moving from hospital to ambulatory or subacute care is a high-risk period for medication errors and also a chance to improve glycemic control and avoid clinical inertia.

    “The transition of persons from the hospital to ambulatory or subacute settings is a high-risk period for medication errors, but also an opportunity to improve glycemic control, avoiding what is often termed clinical inertia.102,1285,1286,1380”

    From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1285]

    The Introduction and Summary discuss diabetes technology and glycemic control during hospitalization, but do not address discharge to ambulatory or subacute care. Searches for discharge transitions, medication errors, and clinical inertia found no passage supporting the attributed claim in our copy. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Davis, G. M., Galindo, R. J., Migdal, A. L., & Umpierrez, G. E.
Affiliations
Emory University (US)
Corresponding author
Umpierrez, Guillermo E.
Venue
Endocrinology and Metabolism Clinics of North America
Publisher
Elsevier BV
Published
2020-03
Volume
49
Issue
1
Pages
79-93
ISSN
0889-8529 (ISSN-L)
OpenAlex
W3002805464
Cited by
62
References
52
Citations by year
2026: 5 · 2025: 9 · 2024: 10 · 2023: 8 · 2022: 10 · 2021: 13 · 2020: 6
FWCI
1.42
Type
journal article
Language
en
Open access
Locations
  • Endocrinology and Metabolism Clinics of North America (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Sanofi
  • National Center for Advancing Translational Sciences (U30, UL1TR002378)
  • National Institutes of Health
  • Novo Nordisk
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK11102)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
diabetes technology, hyperglycemia management, continuous glucose monitoring, insulin pump therapy, artificial pancreas, inpatient glycemic control, hospitalized patients, technology translation
MeSH terms
Blood Glucose, Diabetes Mellitus, Hospitalization, Humans, Hyperglycemia, Inpatients, Insulin, Insulin Infusion Systems, Blood Glucose Self-Monitoring, Pancreas, Artificial, History, 20th Century, History, 21st Century, Inventions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review